Delivery Order SPE2DB24D2018-SPE2DB25FWVB0
Award Date
6/13/25
Potential Completion Date
6/16/25
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REXULTI 1 MG TABLET 30S, a prescription medication, with a ceiling value of $2,655.96 and a period of performance through August 13, 2024. The contract was awarded on August 12, 2024 and is a firm fixed-price, delivery order contract with no set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $11,020.86 and a period of performance through May 20, 2025. The award is not set-aside and was competed openly. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,077.50, is for the delivery of REXULTI 2 MG TABLET 30S, a prescription medication. The contract has a completion date of January 15, 2025 and uses a firm fixed price pricing type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,046.54 firm fixed-price contract is for the delivery of REXULTI 2 MG TABLET 30S, a prescription medication, with a period of performance through May 14, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a $6,945.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a period of performance through April 4, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a firm fixed price ceiling value of $10,092.99. The contract has an ultimate completion date of May 27, 2025. Amerisourcebergen Drug Corp is the prime contractor and this award is part of a larger Indefinite Delivery Contract (IDC) with...
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the supply of REXULTI 2 MG TABLET 30S pharmaceuticals, with a potential value of $13,928.74 and a performance period through February 21, 2024. Amerisourcebergen Drug Corp, as a for-profit prime contractor, provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,230.60 and a period of performance through April 29, 2025. The contract is a firm-fixed-price delivery order, which indicates that the pricing is pre-determined. The contract is not set aside...
This is a delivery order under a Firm Fixed Price contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $16,471.31 and a completion date of July 16, 2024. The award is for the pharmaceutical product REXULTI 2 MG TABLET 30S. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,951.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a completion date of January 3, 2025. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...